Sendai virus-mediated CFTR gene transfer to the airway epithelium
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The potential for gene therapy to be an effective treatment for cystic fibrosis has been hampered by the limited gene transfer efficiency of current vectors. We have shown that recombinant Sendai virus (SeV) is highly efficient in mediating gene transfer to differentiated airway epithelial cells, because of its capacity to overcome the intra- and extracellular barriers known to limit gene delivery. Here, we have identified a novel method to allow the cystic fibrosis transmembrane conductance regulator (CFTR) cDNA sequence to be inserted within SeV (SeV-CFTR). Following in vitro transduction with SeV-CFTR, a chloride-selective current was observed using whole-cell and single-channel patch-clamp techniques. SeV-CFTR administration to the nasal epithelium of cystic fibrosis (CF) mice (Cftr(G551D) and Cftr(tm1Unc)TgN(FABPCFTR)#Jaw mice) led to partial correction of the CF chloride transport defect. In addition, when compared to a SeV control vector, a higher degree of inflammation and epithelial damage was found in the nasal epithelium of mice treated with SeV-CFTR. Second-generation transmission-incompetent F-deleted SeV-CFTR led to similar correction of the CF chloride transport defect in vivo as first-generation transmission-competent vectors. Further modifications to the vector or the host may make it easier to translate these studies into clinical trials of cystic fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although both methods have low reprogramming efficiency, Sendai virus-mediated reprogramming has been used for several clinical applications, notably, in cystic fibrosis, the AIDS vaccine, and other iPSC replacement therapies [29,30,31,32,33].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [31]
Citations
Cites
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., & Welsh, M. J. (1992) · Nature · doi:10.1038/358761a0 · Cited by 1,234
Structure and Function of the CFTR Chloride Channel
SHEPPARD, D. N., & WELSH, M. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s23 · Cited by 1,018
Submucosal glands are the predominant site of CFTR expression in the human bronchus
Engelhardt, J. F., Yankaskas, J. R., Ernst, S. A., Yang, Y., Marino, C. R., Boucher, R. C., Cohn, J. A., & Wilson, J. M. (1992) · Nature Genetics · doi:10.1038/ng1192-240 · Cited by 653
Zhang, L., Peeples, M. E., Boucher, R. C., Collins, P. L., & Pickles, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5654-5666.2002 · Cited by 581
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
Johnson, L. G., Olsen, J. C., Sarkadi, B., Moore, K. L., Swanstrom, R., & Boucher, R. C. (1992) · Nature Genetics · doi:10.1038/ng0992-21 · Cited by 439
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8317 · Cited by 391
Chisari, F. V., Filippi, P., Buras, J., McLachlan, A., Popper, H., Pinkert, C. A., Palmiter, R. D., & Brinster, R. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6909 · Cited by 355
Kobinger, G. P., Weiner, D. J., Yu, Q.-C., & Wilson, J. M. (2001) · Nature Biotechnology · doi:10.1038/85664 · Cited by 307
Zhang, L., Bukreyev, A., Thompson, C. I., Watson, B., Peeples, M. E., Collins, P. L., & Pickles, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1113-1124.2005 · Cited by 302
Efficient gene transfer to airway epithelium using recombinant Sendai virus
Yonemitsu, Y., Kitson, C., Ferrari, S., Farley, R., Griesenbach, U., Judd, D., Steel, R., Scheid, P., Zhu, J., Jeffery, P. K., et al. (2000) · Nature Biotechnology · doi:10.1038/79463 · Cited by 244
Self-citation
Research works printed but not linked: 1
- Aherne WA, Dunnill MS . Point counting and morphometry. In: Aherne WA and Dunnill MS (eds). Morphometry. Arnold E: London, 1982, pp 33–45.
Cited by
FUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411
Self-citationCurrent prospects for mRNA gene delivery
Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 190
Miyamoto, K., Akiyama, M., Tamura, F., Isomi, M., Yamakawa, H., Sadahiro, T., Muraoka, N., Kojima, H., Haginiwa, S., Kurotsu, S., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.010 · Cited by 189
“SeV vectors have been studied for their potential applications in clinical studies of gene therapy for cystic fibrosis, critical limb ischemia, vaccines for HIV, and other areas (Ferrari et al., 2007; Matsumoto et al., 2016; Takeda et al., 2008; Yonemitsu et al., 2000).”
BackgroundSelf-citationGene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy
Griesenbach, U., & Alton, E. W. F. W. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.010 · Cited by 179
“First-generation recombinant SeV carrying the CFTR cDNA can produce functional CFTR chloride channels in vitro and after transfection of the nasal epithelium in CF knockout mice in vivo [57].”
BackgroundSelf-citationPreparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Alton, E. W. F. W., Beekman, J. M., Boyd, A. C., Brand, J., Carlon, M. S., Connolly, M. M., Chan, M., Conlon, S., Davidson, H. E., Davies, J. C., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208406 · Cited by 150
Self-citation
Metadata
- Authors
- Ferrari, S., Griesenbach, U., Iida, A., Farley, R., Wright, A. M., Zhu, J., Munkonge, F. M., Smith, S. N., You, J., Ban, H., Inoue, M., Chan, M., Singh, C., Verdon, B., Argent, B. E., Wainwright, B., Jeffery, P. K., Geddes, D. M., Porteous, D. J., Hyde, S. C., Gray, M. A., Hasegawa, M., & Alton, E. W. F. W.
- Affiliations
- Imperial College London (GB)
- ID Pharma (Japan) (JP)
- Newcastle University (GB)
- The University of Queensland (AU)
- University of Edinburgh (GB)
- University of Oxford (GB)
- Venue
- Gene Therapy
- Published
- 2007-06-28
- Volume
- 14
- Issue
- 19
- Pages
- 1371-1379
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2025492104
- Cited by
- 63
- References
- 45
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 8
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Cystic Fibrosis Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- Sendai virus, cystic fibrosis, CFTR gene therapy, airway epithelium, gene transfer efficiency, chloride transport, nasal epithelium, epithelial inflammation
- MeSH terms
- Aerosols, Animals, Chlorides, Cystic Fibrosis, Epithelial Cells, Female, Genetic Engineering, Genetic Vectors, Iodides, Ion Channels, Lung, Male, Mutation, Transduction, Genetic, Genetic Therapy, Gene Expression, Mice, Knockout, Patch-Clamp Techniques, Cystic Fibrosis Transmembrane Conductance Regulator, Sendai virus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sendai virus-mediated CFTR gene transfer to the airway epithelium. https://app.cochat.ai/papers/10.1038/sj.gt.3302991
- The paper
- Ferrari, S., Griesenbach, U., Iida, A., Farley, R., Wright, A. M., Zhu, J., Munkonge, F. M., Smith, S. N., You, J., Ban, H., Inoue, M., Chan, M., Singh, C., Verdon, B., Argent, B. E., Wainwright, B., Jeffery, P. K., Geddes, D. M., Porteous, D. J., . . . Alton, E. W. F. W. (2007). Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Therapy. https://doi.org/10.1038/sj.gt.3302991
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.